LAUNXP Biomedical Co., Ltd (6876) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of LAUNXP Biomedical Co., Ltd stock NT$1.08, price NT$12.00, that is 91.0% below the price, quality 32 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
LAUNXP Biomedical Co., Ltd
6876 · TWOFar too expensive (fair value 91% below the price) and weak company.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 21, 2026.
How to read this chart
12‑month range NT$9.77 – NT$25.10 · fair‑value band NT$0.714 – NT$1.35 · the NT$12.00 price screens above the NT$1.08 fair value. As of Nov 21, 2026.
Every Wednesday you see whether LAUNXP Biomedical Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
LAUNXP Biomedical Co., Ltd engages in the research and development of drugs for cancer patients.
Show moreShow less
It develops various drugs, which are in preclinical stage, including LXP5948 for non-small cell lung cancer and Alzheimer's disease; LXP5268 for triple negative breast cancer; LXP5101 for pancreatic cancer; LXP1788 for gastrointestinal cancer; and Virus-like particles for cancer and genetic defect treatment.
The company was founded in 2015 and is based in Taichung, Taiwan.
Stock analysis
LAUNXP Biomedical Co., Ltd (6876) currently trades at NT$12.00, while our model-based Fair Value estimate is NT$1.08, 91% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 91/100, which puts the data coverage at low.
Scenario range: NT$0.714 (bear) to NT$1.35 (bull), the price of NT$12.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 32/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
LAUNXP Biomedical Co., Ltd reported revenue of 2.5M TWD in FY2024 versus 0 TWD in FY2021. Reported net income was −82.6M TWD in FY2024.
Key figures
Market cap 991M TWD (≈ $30.1M) Micro · EPS (TTM) NT$-7.83 · Return on assets (EBIT) −71.8% (4-year average) · Free cash flow −77.0M TWD.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (medium confidence).
What moves the price
The share trades about 52% below its 52-week high and 23% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −91%, 6876 screens richer than that median.
Fair Value models
All 1 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare LAUNXP Biomedical Co., Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 854 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- Stock screener with 62 metrics
- Undervalued stocks: Taiwanese Stocks
- Valuation of the Taiwan market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $920.69 | $1,275.02 | +38% | vs 6876 |
| Vertex Pharmaceuticals Incorporated VRTX | $515.02 | $566.52 | +10% | vs 6876 |
| Samsung Biologics Co 207940 | ₩1,355,000 | ₩1,490,500 | +10% | vs 6876 |
| argenx SE ARGX | $925.70 | $908.40 | −2% | vs 6876 |
| CSL Limited CSL | A$197.29 | A$188.80 | −4% | vs 6876 |
| BeOne Medicines AG 6160 | HK$230.80 | HK$152.92 | −34% | vs 6876 |
| Moderna, Inc MRNA | $195.00 | $119.97 | −38% | vs 6876 |
| Revolution Medicines, Inc RVMD | $161.20 | $83.14 | −48% | vs 6876 |
| Celltrion, Inc 068270 | ₩213,000 | ₩74,574 | −65% | vs 6876 |
| Royalty Pharma plc RPRX | $68.45 | $19.01 | −72% | vs 6876 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is LAUNXP Biomedical Co., Ltd (6876) overvalued or undervalued?
What is the fair value of 6876?
What is the quality score of 6876?
What is the price target for LAUNXP Biomedical Co., Ltd (6876)?
What is the LAUNXP Biomedical Co., Ltd stock forecast for 2026?
What is the intrinsic value of LAUNXP Biomedical Co., Ltd (6876)?
Is LAUNXP Biomedical Co., Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 6876?
How much is LAUNXP Biomedical Co., Ltd worth?
What do the bullish and bearish scenarios say about 6876?
How far is 6876 from its 52-week high?
Which stocks are comparable to LAUNXP Biomedical Co., Ltd?
Is LAUNXP Biomedical Co., Ltd stock attractive at the current price?
How is the fair value of 6876 calculated?
Is it still worth investing in stocks now?
What is the share price of LAUNXP Biomedical Co., Ltd (6876)?
What should I pay attention to with LAUNXP Biomedical Co., Ltd right now?
Key figures of LAUNXP Biomedical Co., Ltd
How large is the market capitalisation of LAUNXP Biomedical Co., Ltd (6876)?
What are the earnings per share of LAUNXP Biomedical Co., Ltd (6876)?
What is the EBIT return on assets of LAUNXP Biomedical Co., Ltd (6876)?
How much free cash flow does LAUNXP Biomedical Co., Ltd (6876) generate?
Watch LAUNXP Biomedical Co., Ltd in the live analysis
One click puts LAUNXP Biomedical Co., Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.